Leukotac (Inolimomab)

Inolimomab · ElsaLys Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Leukotac (Inolimomab), covering 2020-12-17 to 2020-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD [Phase 3]